EW.US Edwards Lifesciences Corp

Healthcare Health Care Equipment & Supplies USA Stocks
107.15 USD
Close of Nov 13, 2026
74.66 107.69
Market cap
USD 61.6B
P/E
62.3x
P/B
5.60x
ROE
11.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is EW.US undervalued?

Graham number

The Graham number of Edwards Lifesciences Corp cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Edwards Lifesciences Corp fundamental analysis

No fundamental analysis for Edwards Lifesciences Corp yet.

Edwards Lifesciences Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The…

Full company profile